CID 72942037

Pazopanib metabolite m24

Structural Information

Molecular Formula
C21H23N7O3S
SMILES
CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)CO)C)S(=O)(=O)N
InChI
InChI=1S/C21H23N7O3S/c1-13-4-5-14(10-19(13)32(22,30)31)24-21-23-9-8-20(25-21)27(2)15-6-7-16-17(11-15)26-28(3)18(16)12-29/h4-11,29H,12H2,1-3H3,(H2,22,30,31)(H,23,24,25)
InChIKey
KRXYEFGZHAJXHW-UHFFFAOYSA-N
Compound name
5-[[4-[[3-(hydroxymethyl)-2-methylindazol-6-yl]-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

1
References

0
Patents

453.1583 Da
Monoisotopic Mass

1.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 454.16558 207.2
[M+Na]+ 476.14752 216.9
[M-H]- 452.15102 214.4
[M+NH4]+ 471.19212 213.1
[M+K]+ 492.12146 210.4
[M+H-H2O]+ 436.15556 197.3
[M+HCOO]- 498.15650 222.8
[M+CH3COO]- 512.17215 215.6
[M+Na-2H]- 474.13297 211.0
[M]+ 453.15775 212.5
[M]- 453.15885 212.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.